Abeona Therapeutics (FRA:PCJ) OCF Margin %: -227.10% (As of Mar. 2026)

What is Abeona Therapeutics OCF Margin %?

Abeona Therapeutics FRA:PCJ +0.22% 31 OCF Margin % is -227.10% as of Mar. 2026. GuruFocus rates FRA:PCJ with a GF Score™ of 31/100. The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Abeona Therapeutics ranks worse than 73.93% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Abeona Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was €-17.13 Mil. Abeona Therapeutics's Revenue for the three months ended in Mar. 2026 was €7.54 Mil. Therefore, Abeona Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was -227.10%.

As of today, Abeona Therapeutics's current OCF Yield % is -23.84%.

The historical rank and industry rank for Abeona Therapeutics's OCF Margin % or its related term are showing as below:

FRA:PCJ' s OCF Margin % Range Over the Past 10 Years
Min: -3075.18 Med: -1387.67 Max: -350.19
Current: -533.58

During the past 13 years, the highest OCF Margin % of Abeona Therapeutics was -350.19%. The lowest was -3075.18%. And the median was -1387.67%.

FRA:PCJ's OCF Margin % is ranked worse than
73.93% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs FRA:PCJ: -533.58

Abeona Therapeutics OCF Margin % Related Terms

Abeona Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Abeona Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abeona Therapeutics OCF Margin % Chart

Abeona Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

-2,188.85

-3,074.76

-1,057.56

0.00

-1,311.51

Abeona Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															0.00	-4,693.37	0.00	-331.22	-227.10

FRA:PCJ vs FATE, LCTX, BCYC: OCF Margin % Comparison

For the Biotechnology subindustry, Abeona Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abeona Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abeona Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Abeona Therapeutics's OCF Margin % falls into.

Save Embed

31GF Score

Abeona Therapeutics Inc FRA:PCJ

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Abeona Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Abeona Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-65.182	/	4.97
	=	-1,311.51 %

Abeona Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-17.13	/	7.543
	=	-227.10 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -227.10% mean?

Abeona Therapeutics (FRA:PCJ) has a OCF Margin % of -227.10% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Abeona Therapeutics and its competitors. According to the industry distribution chart, Abeona Therapeutics ranks #709 out of 959 companies in the Biotechnology industry, placing it in the top 73.9%.

Is Abeona Therapeutics' OCF Margin % too high?

Abeona Therapeutics' current OCF Margin % is -227.10%. Based on the distribution chart, Abeona Therapeutics ranks #709 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Abeona Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.

How does Abeona Therapeutics' OCF Margin % compare to FATE and LCTX?

According to the Biotechnology industry distribution chart, Abeona Therapeutics ranks #709 out of 959 companies for OCF Margin %. This places Abeona Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Abeona Therapeutics and its competitors. Abeona Therapeutics's current OCF Margin % is -227.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Abeona Therapeutics stock overvalued right now?

Abeona Therapeutics (FRA:PCJ) has a current OCF Margin % of -227.10%. The current OCF Margin % is -227.10%. Abeona Therapeutics' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Abeona Therapeutics (FRA:PCJ), the current OCF Margin % is -227.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abeona Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies FATE LCTX BCYC RCKT IVVD DMAC NMRA RZLT TENX NAUT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ABEO:USA 0H7R:UK PCJ:Germany

Address 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, USA, 44103

Website https://www.abeonatherapeutics.com

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

31GF Score

Get the complete analysis for FRA:PCJ

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.90

Price

View FRA:PCJ Analysis

See OCF Margin % data for all stocks →